Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 4Radiotherapy, Intensity-Modulated 2Low-Level Light Therapy 2Chemotherapy, Adjuvant 2olaparib 1Sodium Chloride 1Respiratory Physiological Phenomena 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Proton Therapy 1Poly A 1Oxygen 1Mometasone Furoate 1Mass Screening 1Lymph Node Excision 1Lovastatin 1Hyperbaric Oxygenation 1Gene Expression Profiling 1G(M1) Ganglioside 1Flow Cytometry 1Enzyme-Linked Immunosorbent Assay 1Diagnosis 1Centella asiatica extract 1Blood Specimen Collection 1Adenosine Diphosphate Ribose 1Adenosine Diphosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Mometasone Furoate × Breast × Clear all
NCT00438659 2016-08-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Alliance for Clinical Trials in Oncology

Phase 3 Completed
176 enrolled 10 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiation Injuries, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡